BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Cases. Oct 26, 2026; 14(28): 127546
Published online Oct 26, 2026. doi: 10.12998/wjcc.127546
Table 1 Baseline laboratory workup of the patient
Parameter
Patient value
Reference range
Hemoglobin (g/dL)11.112.0-15.0
Total leukocyte count (×103/mm3)9.354.0-11.0
Neutrophils (%)61.840-75
Platelet count (×103/mm3)435150-450
Total bilirubin (mg/dL)0.560.2-1.2
Direct bilirubin (mg/dL)-0.0-0.3
AST (IU/L)155-40
ALT (IU/L)125-40
ALP (IU/L)9740-129
Total protein (g/dL)7.86.0-8.3
Albumin (g/dL)3.13.5-5.2
Sodium (mEq/L)137135-145
Potassium (mEq/L)4.03.5-5.1
Urea (mg/dL)2015-45
Serum creatinine (mg/dL)0.790.6-1.2
Serum calcium (mg/dL)10.68.5-10.5
PT/INR (Sec)15/1.411-13.5/0.8-1.1
Table 2 Workup for plasma cell dyscrasia
Parameters
Patient value
Reference range
M-Spike2.27 g/dL (27.8%) (present)Present/absent
Serum free kappa light chain (mg/L)16.143.3-19.4
Serum free lambda light chain (mg/L)752.405.7-26.3
Free κ/λ ratio0.020.26-1.65
Urine Bence Jones proteinNegativeNegative
Spot protein creatinine ratio100< 150 mg/g
Whole body PET-CTDiffuse circumferential esophageal wall thickening (up to 7 mm) without significant FDG uptake, no hypermetabolic lesions seen elsewhere
Table 3 Selected previously published case reports and case series of esophageal amyloidosis
Ref.
Study type
Age, sex
Clinical presentation
Endoscopic findings
Type of amyloidosis
Treatment and outcome
Shatnawei et al[13]Case report70, maleHematemesis, DysphagiaUlcerated mucosaNRSymptom resolution
Fujiya et al[18]Case report72, maleAsymptomatic, Incidental findingsSubepithelial lesion in proximal esophagusAL (λ)-type localized esophageal amyloidosisOn close follow-up, no symptoms occurred
Ailawadi et al[17]Case report74, maleDysphagiaDistal esophageal stricture and endoscopically normal mucosa, but a biopsy-positive lesion in the proximal esophagusNRNot reported
Merchant et al[21]Case report79, maleDysphagia and weight lossFluid-filled esophagus; manometry: Type 2 achalasiaNRSymptoms improved with peroral endoscopic myotomy
Ranjan et al[22]Case report65, femaleDysphagiaEndoscopy/barium swallow normal; manometry showed low-amplitude, non-propulsive contractionsMultiple myelomaNR
Ng et al[23]Case report85, maleDysphagiaLarge globular mass in the posterior pharyngeal wall and esophageal inletATTR variantExpired
Bhavani et al[24]Case report44, femaleDysphagiaPost-cricoid strictureNRNR
Cowan et al[4]Case series (n = 76; Esophageal: 6)Male: 62%; age: 61 (median)Weight loss, heart burnNRAL - systemicMortality in 4%
Palchaudhuri et al[25]Case report69, maleAcute food bolus obstructionStricture and ulceration in mid esophagusNRExpired
Kahi et al[26]Case report47/maleDysphagiaSubmucosal tumor-like lesion in the esophagusAL (κ) - AmyloidosisStable, without treatment
Wongjarupong et al[27]Case report72/maleDysphagiaNormal endoscopy; manometry: Type II achalasiaAL (κ), associated with multiple myelomaLocalized Botulinum toxin, partial improvement
Prokaeva et al[28]Case report66/maleAbdominal pain, weight lossMultiple diminutive nodules in middle third of esophagusHereditary AApoAI, novel APOA1 p.Trp96Arg (W72R)Observation/follow-up; no new organ involvement over approximately 6 years


Write to the Help Desk